泰格医药:2025年年度报告摘要
Zheng Quan Ri Bao· 2026-03-30 13:53
Core Insights - The company reported a revenue of 6,832,800,615.35 yuan for the fiscal year 2025, reflecting a year-on-year growth of 3.48% [1] - The net profit attributable to shareholders reached 887,890,076.31 yuan, showing a significant increase of 119.15% compared to the previous year [1] Financial Performance - Revenue for 2025: 6.83 billion yuan, up 3.48% year-on-year [1] - Net profit for 2025: 887.89 million yuan, up 119.15% year-on-year [1]
中国东方集团(00581.HK):2025年纯利为2.25亿元 同比增加50.9%
Ge Long Hui· 2026-03-30 13:48
Core Viewpoint - China Oriental Group (00581.HK) reported a revenue of RMB 40.413 billion for the year ending December 31, 2025, representing a year-on-year decrease of 5.9% [1] Financial Performance - Gross profit reached RMB 2.493 billion, showing a significant year-on-year increase of 40.6% [1] - Profit attributable to equity holders was RMB 225 million, reflecting a year-on-year increase of 50.9% [1] - Basic earnings per share were RMB 0.06, with a proposed final dividend of HKD 0.02 per share and a special dividend of HKD 0.05 per share [1] Industry Context - The steel industry faced continued weak demand for downstream products, leading to a decline in average selling prices of steel products [1] - Despite the challenges, net profit for 2025 increased due to several factors, including: - A decline in major raw material prices, which fell faster than the prices of steel products [1] - Ongoing implementation of lean management strategies, including cost reduction, efficiency improvement, and management optimization [1] - An annual increase in the production and sales volume of steel products, contributing to overall gross profit improvement [1] Strategic Response - The company is actively addressing macroeconomic fluctuations and deep industry adjustments through core strategies focused on innovation, green transformation, enhanced management, and promoting high-quality development [1]
康龙化成:关于2026年度套期保值产品交易额度预计的公告
Zheng Quan Ri Bao Zhi Sheng· 2026-03-30 13:47
Core Viewpoint - Kanglong Chemical announced plans to continue engaging in hedging transactions to mitigate foreign exchange risks, with an estimated trading limit of 1.8 billion USD for 2026 [1] Group 1: Hedging Strategy - The company will conduct hedging transactions including forward foreign exchange, swap transactions, foreign exchange options, and other financial derivatives [1] - The estimated trading limit for hedging products is set at 1.8 billion USD or equivalent foreign currency for the year 2026 [1] - The trading limit can be reused within the trading period, and any transaction amount at any point during the trading period will not exceed this limit [1]
中国银行行长张辉:科技金融领域已形成新的差异化优势,科技贷款余额突破4.8万亿
Xin Lang Cai Jing· 2026-03-30 13:45
炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 中国银行今日召开2025年年度业绩发布会。行长张辉表示,中国银行在科技金融领域已经形成了四大差 异化优势———结构优势持续凸显、客群基础不断夯实、综合服务成效显著、科技型企业资产质量保持 良好。科技金融已经成为推动全行高质量发展的新引擎。 责任编辑:宋雅芳 新浪声明:新浪网登载此文出于传递更多信息之目的,并不意味着赞同其观点或证实其描述。文章内容 仅供参考,不构成投资建议。投资者据此操作,风险自担。 ...
泰格医药(300347.SZ):2025年净利润同比增长119.15% 拟10股派1.26元


Ge Long Hui A P P· 2026-03-30 13:43
格隆汇3月30日丨泰格医药(300347.SZ)公布2025年年度报告,营业收入68.3亿元,同比增长3.48%,归属 于上市公司股东的净利润8.88亿元,同比增长119.15%,归属于上市公司股东的扣除非经常性损益的净 利润3.55亿元,同比下降58.47%。向全体股东每10股派发现金红利1.26元。 ...
泰格医药:关于董事会换届选举的公告


Zheng Quan Ri Bao Zhi Sheng· 2026-03-30 13:43
Core Viewpoint - Tiger Medical announced the nomination of candidates for its sixth board of directors during the 23rd meeting of the fifth board, scheduled for March 30, 2026 [1] Group 1: Board of Directors - The company proposed Ye Xiaoping, Cao Xiaochun, Wu Hao, and Wen Zengyu as candidates for executive directors of the sixth board [1] - The company nominated Yuan Huagang, Liu Yuwen, and Xiao Yaoxi as candidates for independent non-executive directors of the sixth board [1]
泰格医药:董事会审议通过《关于公司2025年度报告全文、报告摘要及2025年度业绩公告的议案》等多项议案
Zheng Quan Ri Bao Zhi Sheng· 2026-03-30 13:43
Core Viewpoint - The company, Tigermed, announced the approval of several key proposals during its fifth board meeting, including the full report and summary for the 2025 annual performance, profit distribution plan, and the nomination of candidates for the sixth board of directors [1] Group 1 - The company approved the proposal for the full text and summary of the 2025 annual report and performance announcement [1] - The company also approved the proposal for the 2025 annual profit distribution plan [1] - The company nominated candidates for the sixth board of directors during the meeting [1]
港股比亚迪电子跌超5%



Mei Ri Jing Ji Xin Wen· 2026-03-30 13:40
Group 1 - BYD Electronics (00285.HK) experienced a decline of over 5%, with a current drop of 5.56%, trading at 28.9 HKD [1] - The trading volume reached 776 million HKD [1]
海尔智家(06690)3月30日斥资5819.3万元回购270万股A股


智通财经网· 2026-03-30 13:37
Group 1 - The company Haier Smart Home (06690) announced a share buyback plan, intending to repurchase 2.7 million A-shares at a cost of 58.193 million yuan [1]
港股广汽集团跌超5%
Mei Ri Jing Ji Xin Wen· 2026-03-30 13:32
Group 1 - GAC Group (02238.HK) experienced a decline of over 5%, specifically a drop of 5.31%, trading at 3.03 HKD as of the report [1] - The trading volume reached 63.96 million HKD [1]